Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease
Top Cited Papers
Open Access
- 24 May 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 123 (20) , 2263-2273
- https://doi.org/10.1161/circulationaha.110.981738
Abstract
No abstract availableKeywords
This publication has 131 references indexed in Scilit:
- Structure of Cinaciguat (BAY 58–2667) Bound to Nostoc H-NOX Domain Reveals Insights into Heme-mimetic Activation of the Soluble Guanylyl CyclaseJournal of Biological Chemistry, 2010
- Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation‐induced degradationBritish Journal of Pharmacology, 2009
- Cellular and Molecular Basis of Pulmonary Arterial HypertensionPublished by Elsevier ,2009
- Updated Evidence-Based Treatment Algorithm in Pulmonary Arterial HypertensionJournal of the American College of Cardiology, 2009
- Cyclic GMP signaling in cardiovascular pathophysiology and therapeuticsPharmacology & Therapeutics, 2009
- Probing the presence of the ligand‐binding haem in cellular nitric oxide receptorsBritish Journal of Pharmacology, 2008
- Cyclic GMP and protein kinase‐G in myocardial ischaemia‐reperfusion: opportunities and obstacles for survival signalingBritish Journal of Pharmacology, 2007
- Inhaled NO as a therapeutic agentCardiovascular Research, 2007
- NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potentialNature Reviews Drug Discovery, 2006
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005